Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2011

Feb 24, 2011

30339_dirs_2011-02-24_db7e8e3e-a098-41f5-8e0a-da7ccdd62cd4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2011-02-22

Reporting Person: ELLERS STEVEN A (COO & President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-02-22 Common Stock A 4585.0000 $40.8500 Acquired 156543.8728 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3498.2821 Indirect
Common Stock 20414.5077 Indirect

Footnotes

F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2008 that have vested for performance period 7.